Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial
- PMID: 18364384
- PMCID: PMC2435639
- DOI: 10.1210/jc.2007-1473
Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial
Abstract
Background: Although weight loss and exercise ameliorates frailty and improves cardiac risk factors in obese older adults, the long-term effect of lifestyle intervention on bone metabolism and mass is unknown.
Objective: The objective was to evaluate the effects of diet-induced weight loss in conjunction with exercise on bone metabolism and mass in obese older adults.
Design and setting: We conducted a one-year randomized, controlled clinical trial in a university-based research center.
Participants: Twenty-seven frail, obese (body mass index = 39 +/- 5 kg/m(2)), older (age 70 +/- 5 yr) adults participated in the study.
Intervention: Participants were randomly assigned to diet and exercise (treatment group; n = 17) or no therapy (control group; n = 10).
Outcome measures: Body weight decreased in the treatment group but not in the control group (-10 +/- 2 vs. +1 +/- 1%, P < 0.001). Compared with the control group, the treatment group had greater changes in bone mass, bone markers, and hormones, including 1) bone mineral density (BMD) in total hip (0.1 +/- 2.1 vs. -2.4 +/- 2.5%), trochanter (0.2 +/- 3.3 vs. -3.3 +/- 3.1%), and intertrochanter (0.3 +/- 2.7 vs. -2.7 +/- .3.0%); 2) C-terminal telopeptide (12 +/- 35 vs. 101 +/- 79%) and osteocalcin (-5 +/- 15 vs. 66 +/- 61%); and 3) leptin (2 +/- 12 vs. -30 +/- 25%) and estradiol (0.1 +/- 14% vs. -14 +/- 21%) (all P < 0.05). Changes in weight (r = 0.55), bone markers (r = -0.54), and leptin (r = 0.61) correlated with changes in hip BMD (all P < 0.05).
Conclusion: Weight loss, even when combined with exercise, decreases hip BMD in obese older adults. It is not known whether the beneficial effects of weight loss and exercise on physical function lower the overall risk of falls and fractures, despite the decline in hip BMD.
Figures
Similar articles
-
Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults.Osteoporos Int. 2014 Feb;25(2):551-8. doi: 10.1007/s00198-013-2450-2. Epub 2013 Jul 27. Osteoporos Int. 2014. PMID: 23892583 Free PMC article. Clinical Trial.
-
Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones.J Bone Miner Res. 2011 Dec;26(12):2851-9. doi: 10.1002/jbmr.475. J Bone Miner Res. 2011. PMID: 21786319 Free PMC article. Clinical Trial.
-
Effect of Aerobic or Resistance Exercise, or Both, on Bone Mineral Density and Bone Metabolism in Obese Older Adults While Dieting: A Randomized Controlled Trial.J Bone Miner Res. 2020 Mar;35(3):430-439. doi: 10.1002/jbmr.3905. Epub 2019 Dec 4. J Bone Miner Res. 2020. PMID: 31797417 Free PMC article. Clinical Trial.
-
Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.J Bone Miner Res. 2015 Dec;30(12):2168-78. doi: 10.1002/jbmr.2564. Epub 2015 Jun 16. J Bone Miner Res. 2015. PMID: 26012544 Review.
-
Weight Loss-Induced Reduction of Bone Mineral Density in Older Adults with Obesity.J Nutr Gerontol Geriatr. 2019 Jan-Mar;38(1):100-114. doi: 10.1080/21551197.2018.1564721. Epub 2019 Feb 22. J Nutr Gerontol Geriatr. 2019. PMID: 30794099 Free PMC article. Review.
Cited by
-
The Impact of Interventional Weight Loss on Bone Marrow Adipose Tissue in People Living with Obesity and Its Connection to Bone Metabolism.Nutrients. 2023 Oct 29;15(21):4601. doi: 10.3390/nu15214601. Nutrients. 2023. PMID: 37960254 Free PMC article. Review.
-
The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus.Medicine (Baltimore). 2023 Sep 29;102(39):e35394. doi: 10.1097/MD.0000000000035394. Medicine (Baltimore). 2023. PMID: 37773814 Free PMC article. Clinical Trial.
-
New Insights into Calorie Restriction Induced Bone Loss.Endocrinol Metab (Seoul). 2023 Apr;38(2):203-213. doi: 10.3803/EnM.2023.1673. Epub 2023 Apr 27. Endocrinol Metab (Seoul). 2023. PMID: 37150516 Free PMC article.
-
Intermittent fasting and bone health: a bone of contention?Br J Nutr. 2023 Nov 14;130(9):1487-1499. doi: 10.1017/S0007114523000545. Epub 2023 Mar 6. Br J Nutr. 2023. PMID: 36876592 Free PMC article. Review.
-
The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.Obesity (Silver Spring). 2023 Feb;31 Suppl 1(Suppl 1):85-95. doi: 10.1002/oby.23577. Epub 2022 Oct 14. Obesity (Silver Spring). 2023. PMID: 36239695 Free PMC article. Clinical Trial.
References
-
- Villareal DT, Banks M, Siener C, Sinacore DR, Klein S 2004 Physical frailty and body composition in obese elderly men and women. Obes Res 12:913–920 - PubMed
-
- Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP 2005 The association between obesity and the frailty syndrome in older women: the Women’s Health and Aging Studies. J Am Geriatr Soc 53:927–934 - PubMed
-
- Zizza CA, Herring A, Stevens J, Popkin BM 2002 Obesity affects nursing-care facility admission among whites but not blacks. Obes Res 10:816–823 - PubMed
-
- Arterburn DE, Crane PK, Sullivan SD 2004 The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc 52:1907–1912 - PubMed
-
- Villareal DT, Banks M, Sinacore DR, Siener C, Klein S 2006 Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med 166:860–866 - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG025501/AG/NIA NIH HHS/United States
- M01 RR000036/RR/NCRR NIH HHS/United States
- AG 2116401/AG/NIA NIH HHS/United States
- AG 00078/AG/NIA NIH HHS/United States
- AG 025501/AG/NIA NIH HHS/United States
- RR 00036/RR/NCRR NIH HHS/United States
- R01 DK037948/DK/NIDDK NIH HHS/United States
- DK 56341/DK/NIDDK NIH HHS/United States
- T32 AG000078/AG/NIA NIH HHS/United States
- DK 37948/DK/NIDDK NIH HHS/United States
- P30 DK056341-08/DK/NIDDK NIH HHS/United States
- P30 DK056341/DK/NIDDK NIH HHS/United States
- P30 DK056341-07/DK/NIDDK NIH HHS/United States
